Trusted by 100,000+ International Patients
Brain Cancer Treatment: Turkey vs United Kingdom
Cost, Quality & Recovery Compared
$8650
Turkey Starting Cost
$50000
United Kingdom Starting Cost
See how these top medical tourism destinations compare for Brain Cancer Treatment.
| Comparison Factor | Turkey | United Kingdom | Winner |
|---|---|---|---|
| Average Cost (in USD) | 8650 - 29000 | 50000 - 150000 | Turkey |
| Success Rate (Min and Max) | 83% disease control benchmarks | - | Both Equal |
| Advanced Technology | Advanced neuro-oncology centres with neuronavigation, IMRT/VMAT, and SRS in tertiary hospitals. | - | Both Equal |
| JCI Accredited Hospitals | 25+ | - | Both Equal |
| Visa Process | Medical Visa / eVisa (5–10 working days) | - | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Rutherford Cancer Centre South Wales , The London Clinic , Shirley Oaks Hospital , St Edmunds Hospital
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Turkey and United Kingdom maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
25+ JCI-accredited hospitals operating under the Turkish Ministry of Health hospital quality and safety standards.
Leading cancer centres report strong surgical outcomes and survival rates supported by multidisciplinary neuro-oncology care.
Brain cancer treatment regulated by the National Medical Commission and Ministry of Health oncology care standards.
The United Kingdom offers highly regulated neuro-oncology care through NHS and private hospitals overseen by the Care Quality Commission (CQC), with several centres holding international accreditations and affiliations.
Brain cancer treatment outcomes in the UK are among the best globally, supported by experienced neurosurgeons, advanced radiotherapy technologies, and multidisciplinary tumour boards ensuring personalised care.
Healthcare is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and NHS clinical governance systems, ensuring strict adherence to safety, ethical standards, and advanced oncology protocols.
| Quality Metric | Turkey | United Kingdom |
|---|---|---|
Accredited Hospitals | 25+ | 10–15 |
Average Success Rate | 60%-90% | 75% – 92% |
Advanced RT (IMRT/VMAT/SRS) | Yes (major centres) | Widely available in major cancer centres |
Neuronavigation Availability | Yes (tertiary) | Available in all leading tertiary hospitals |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Dedicated neuro-oncology programs integrating neurosurgery, radiation oncology, and medical oncology for comprehensive brain tumor management.
High patient volumes in major tertiary hospitals with experienced neurosurgeons performing complex brain tumor resections annually.
Highly specialised multidisciplinary neuro-oncology teams including neurosurgeons, radiation oncologists, and medical oncologists experienced in complex brain tumour management and advanced surgical techniques
High-volume centres with extensive experience in complex and rare brain tumours, including participation in international clinical trials
View All Brain Cancer Treatment Surgeons in United Kingdom →
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Tertiary hospitals are equipped with neuronavigation systems, intraoperative MRI/CT, advanced ICUs, and modern radiotherapy units.
Luxury healthcare experience
Advanced tertiary hospitals with intraoperative imaging, neuronavigation systems, stereotactic radiosurgery platforms, proton therapy (select centres), neuro-ICUs, and integrated oncology departments
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after Brain Cancer Treatment in both countries.
Patients remain hospitalised for brain tumour surgery or therapy, post-operative monitoring, and early neurological recovery care.
Recommended local stay: 10–14 days for recovery, review, and RT planning, if needed.
Often 3–4 weeks post-surgery, depending on stability and ongoing RT schedule.
Surgical recovery 6–8 weeks; oncology treatment course may extend 2–6+ months.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
Patients remain hospitalised for brain tumour surgery or therapy, post-operative monitoring, and early neurological recovery care.
Recommended local stay: 10–14 days for recovery, review, and RT planning, if needed.
Often 3–4 weeks post-surgery, depending on stability and ongoing RT schedule.
Surgical recovery 6–8 weeks; oncology treatment course may extend 2–6+ months.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
Brain Cancer Treatment recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your Brain Cancer Treatment journey.
Recognised neurosurgical risks; minimised via ICU monitoring and protocols.
Edema and headaches are possible; steroids and monitoring are used.
Depends on wound healing and neurological status; rehab may be needed.
Neurological deficits, seizures, CSF leak; risks depend on tumor location
Steroids can cause metabolic effects; anti-seizure meds can cause drowsiness; monitored.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Ideal candidates include patients with resectable brain tumors or those needing biopsy and integrated neuro-oncology care, including RT/chemo.
Ideal candidates include patients with resectable brain tumors or those needing biopsy and integrated neuro-oncology care, including RT/chemo.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your Brain Cancer Treatment journey.
Verify tumor type and grade through MRI and biopsy to determine the appropriate neuro-oncology treatment plan.
Select a specialised centre with experienced neurosurgeons and neuro-oncology teams for complex brain tumor management.
Coordinate radiotherapy and chemotherapy schedules, as these treatments often continue for several weeks.
Coordinate radiotherapy and chemotherapy schedules, as these treatments often continue for several weeks.
Schedule regular MRI scans after treatment to monitor recovery and detect any recurrence early.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
